Intradermal Injections Market Scope And Analysis

  • Report Code : TIPRE00019998
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Intradermal injection Market Analysis, Scope, and Growth by 2028

Buy Now


Intradermal Injection Market Report Scope

Report Attribute Details
Market size in 2023 US$ 4.37 Billion
Market Size by 2031 US$ 10.36 Billion
Global CAGR (2023 - 2031) 11.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Method
  • Normal Sized Needles
  • Short Needle
  • Without Needle
By Application
  • Tuberculin Skin Test
  • Allergy Test
  • Local Aesthetics
By End User
  • Hospitals
  • Diagnostic Laboratories
  • Academics and Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BD
  • Terumo Corporation
  • NanoPass
  • Pharmajet
  • Idevax
  • Eunsung Global
  • West Pharmaceutical Services Inc
  • Crossject
  • Cardinal Health Inc
  • Hindustan Syringes and Medical Devices Ltd
  • Intradermal Injection Market News and Recent Developments

    The Intradermal Injection market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes essential corporate publications, association data, and databases. A few of the developments in the Intradermal Injection market are listed below:

    • NanoPass Technologies and Aesthetic Management Partners entered into an agreement to initiate the commercialization of NanoPass’s MicronJet 600 intradermal delivery device in the US. (Source: NanoPass Technologies, Press Release, November 2021).
    • PharmaJet and Zydus Cadila received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world’s first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is solely administered utilizing the PharmaJet Tropis Needle-free Injection System. (Source: PharmaJet, Press Release, August 2021).

    Intradermal Injection Market Report Coverage and Deliverables

    The “Intradermal Injection Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Intradermal injection market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Intradermal injection market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Intradermal injection market analysis covering key market trends, global and regional framework, significant players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the intradermal injection market
    • Detailed company profiles